GMED
Price
$75.58
Change
+$1.17 (+1.57%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
10.04B
39 days until earnings call
Intraday BUY SELL Signals
SRTS
Price
$2.98
Change
+$0.03 (+1.02%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
49.3M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GMED vs SRTS

GMED vs SRTS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GMED vs. SRTS commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Hold and SRTS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
GMED vs SRTS: Fundamental Ratings
GMED
SRTS
OUTLOOK RATING
1..100
1261
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6597
PRICE GROWTH RATING
1..100
5774
P/E GROWTH RATING
1..100
5413
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRTS's Valuation (67) in the Medical Specialties industry is in the same range as GMED (76). This means that SRTS’s stock grew similarly to GMED’s over the last 12 months.

SRTS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as GMED (100). This means that SRTS’s stock grew similarly to GMED’s over the last 12 months.

GMED's SMR Rating (65) in the Medical Specialties industry is in the same range as SRTS (97). This means that GMED’s stock grew similarly to SRTS’s over the last 12 months.

GMED's Price Growth Rating (57) in the Medical Specialties industry is in the same range as SRTS (74). This means that GMED’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's P/E Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for GMED (54). This means that SRTS’s stock grew somewhat faster than GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDSRTS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (GMED: $74.41 vs. SRTS: $2.95)
Brand notoriety: GMED and SRTS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GMED: 101% vs. SRTS: 12%
Market capitalization -- GMED: $10.04B vs. SRTS: $49.3M
GMED [@Medical/Nursing Services] is valued at $10.04B. SRTS’s [@Medical/Nursing Services] market capitalization is $49.3M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green while SRTS’s FA Score has 1 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • SRTS’s FA Score: 1 green, 4 red.
According to our system of comparison, SRTS is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 6 TA indicator(s) are bullish while SRTS’s TA Score has 3 bullish TA indicator(s).

  • GMED’s TA Score: 6 bullish, 4 bearish.
  • SRTS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GMED is a better buy in the short-term than SRTS.

Price Growth

GMED (@Medical/Nursing Services) experienced а +0.19% price change this week, while SRTS (@Medical/Nursing Services) price change was +1.37% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.96%. For the same industry, the average monthly price growth was -5.79%, and the average quarterly price growth was -2.63%.

Reported Earning Dates

GMED is expected to report earnings on Nov 10, 2026.

SRTS is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.96% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
GMED
Daily Signal:
Gain/Loss:
SRTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DDSQ21.48N/A
N/A
Innovator Equity Dual Directional 5 Buffer ETF - Quarterly (DDSQ)
ZCBE49.08N/A
N/A
Global X Zero Coupon Bond 2033 ETF (ZCBE)
VBCJ70.82-0.11
-0.15%
Vanguard Target Maturity 2036 Corporate Bond ETF (VBCJ)
SEIE35.35-0.44
-1.24%
SEI Select International Equity ETF (SEIE)
PTH59.66-1.10
-1.81%
Invesco Dorsey Wright Healthcare Momentum ETF (PTH)

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with TMCI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.65%
TMCI - GMED
46%
Loosely correlated
-2.48%
TNDM - GMED
46%
Loosely correlated
+1.16%
MDT - GMED
44%
Loosely correlated
+0.17%
SYK - GMED
44%
Loosely correlated
-0.88%
ILMN - GMED
42%
Loosely correlated
-2.90%
More

SRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
-1.34%
LUNG - SRTS
57%
Loosely correlated
N/A
HAE - SRTS
45%
Loosely correlated
-0.88%
AORT - SRTS
35%
Loosely correlated
-3.90%
GMED - SRTS
33%
Loosely correlated
-0.65%
MTD - SRTS
28%
Poorly correlated
-1.97%
More